Business model

Business model

Within the business area of drug delivery, Nanologica has several ways of working and collaborating;

  • Licensing agreements/ technology transfer – developing new products for partner products
  • Technology provider – Fee for service contracts and feasibility trials
  • Development of own assets – Internal development programs

If you would like to know more about Nanologica’s different Drug Development projects and collaboration opportunities, please contact Kia Bengtsson, Director Drug Development kia.bengtsson@nanologica.com